Paris,  January 2026 — Linio Biotech is excited to participate in this year’s IMCAS World Congress, where our team will meet with selected customers, partners, and global experts to explore the future of regenerative aesthetics.

A centerpiece of the week will be our Advisory Board meeting, bringing together distinguished KOLs and strategic advisors who will contribute to shaping Linio’s next phase of scientific and clinical development.

“IMCAS brings together the global community shaping the future of aesthetic and regenerative medicine,” said Karita Reijonsaari, CEO of Linio Biotech. “We look forward to an inspiring week of scientific exchange and to engaging with partners who share our commitment to long‑term, regenerative solutions that go beyond traditional aesthetic treatments.”

This year, our focus is on meaningful dialogue: listening, learning, and strengthening the collaborations that will guide our innovation in regenerative aesthetics.

We look forward to an inspiring week in Paris and to reconnecting with colleagues across the global aesthetic and regenerative medicine community.

If you plan to attend IMCAS and would like to connect, please contact info@linio-biotech.com. We would be delighted to hear from you.

‍